Pay in 4 interest-free payments of $7.36 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
8 : e61965
AstraZeneca advanced elecoglipron, an oral small-molecule GLP-1 receptor agonist, toward a Phase III program after positive Phase IIb results in adults with obesity or overweight and type 2 diabetes
Bacteriostatic wateroften called BAC wateris not just sterile water
How GLP-1s Work in the Body Slow gastric emptying (food stays in the stomach longer) Increase satiety signals to the brain Reduce appetite and overall intake Improve insulin response and glycemic control While these effects support metabolic health, slower digestion is also what sets the stage for GI symptoms, including reflux. Digestive Impact of GLP-1s: What the Research Shows Increased Upper GI Symptoms One of the most consistent findings across GLP-1 clinical trials is the high rate of gastrointestinal side effects
2016;11(6):e0157700
US$ 27.58
US$ 27.83
US$ 28.23
